Skip to main navigation Skip to search Skip to main content

Biology of glioma cancer stem cells

  • Cleveland Clinic Foundation

Research output: Contribution to journal › Short survey › peer-review

132 Scopus citations

Abstract

Gliomas, much like other cancers, are composed of a heterogeneous mix of neoplastic and non-neoplastic cells that include both native and recruited cells. There is extensive diversity among the tumor cells, with differing capacity for in vitro and in vivo growth, a property intimately linked to the cell's differentiation status. Those cells that are undifferentiated, self-renewing, with the capacity for developing tumors (tumorigenic) cells are designated by some as cancer stem cells, because of the stem-like properties. These cells may be a critical therapeutic target. However the exact identity and cell(s) of origin of the so-called glioma cancer stem cell remain elusive. Here we review the current understanding of glioma cancer stem cell biology.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalMolecules and Cells
Volume28
Issue number1
DOIs
StatePublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Brain tumor
  • Cancer stem cell
  • Glioblastoma
  • Glioma

Fingerprint

Dive into the research topics of 'Biology of glioma cancer stem cells'. Together they form a unique fingerprint.

Cite this